Literature DB >> 28153825

Tissue tolerance: a distinct concept to control acute GVHD severity.

Shin-Rong Wu1,2, Pavan Reddy2.   

Abstract

Target tissue damage occurs as a consequence of pathological immune responses following allogeneic stem cell transplantation resulting in acute graft-versus-host disease (GVHD). Among those who study infections in plants, it is well recognized that tissues play a distinct role from the immune system in mediating disease severity. Recently, this has also been appreciated in mammals. However, the severity of immunopathology in the context of alloimmune diseases such as acute GVHD has been mainly understood and managed by direct targeting of immune cells to generate immune tolerance. The role of tissue-intrinsic factors that might contribute to regulation of acute GVHD severity has been largely overlooked. Here, we introduce the concept of "tissue tolerance" to discuss the tissue-specific programs that contribute to target tissue resilience, repair, and regeneration, and mitigate severity of acute GVHD without altering the load or function of alloreactive immune cells.
© 2017 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2017        PMID: 28153825      PMCID: PMC5374290          DOI: 10.1182/blood-2016-09-740431

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

Review 1.  Tolerance of infections.

Authors:  Janelle S Ayres; David S Schneider
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

2.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

3.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

Authors:  Maria Van der Sluis; Barbara A E De Koning; Adrianus C J M De Bruijn; Anna Velcich; Jules P P Meijerink; Johannes B Van Goudoever; Hans A Büller; Jan Dekker; Isabelle Van Seuningen; Ingrid B Renes; Alexandra W C Einerhand
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

4.  Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.

Authors:  D Przepiorka; C Ippoliti; I Khouri; M Woo; R Mehra; D Le Bherz; S Giralt; J Gajewski; H Fischer; H Fritsche; A B Deisseroth; K Cleary; R Champlin; K Besien; B Andersson; R Maher; W Fitzsimmons
Journal:  Blood       Date:  1996-12-01       Impact factor: 22.113

5.  An essential role for XBP-1 in host protection against immune activation in C. elegans.

Authors:  Claire E Richardson; Tristan Kooistra; Dennis H Kim
Journal:  Nature       Date:  2010-02-25       Impact factor: 49.962

6.  Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice.

Authors:  A Panoskaltsis-Mortari; D L Lacey; D A Vallera; B R Blazar
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

7.  Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation.

Authors:  Ying-Jun Chang; Lan-Ping Xu; Yu Wang; Xiao-Hui Zhang; Huan Chen; Yu-Hong Chen; Feng-Rong Wang; Wei Han; Yu-Qian Sun; Chen-Hua Yan; Fei-Fei Tang; Xiao-Dong Mo; Kai-Yan Liu; Xiao-Jun Huang
Journal:  J Clin Oncol       Date:  2016-04-18       Impact factor: 44.544

8.  Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.

Authors:  D Weisdorf; R Haake; B Blazar; W Miller; P McGlave; N Ramsay; J Kersey; A Filipovich
Journal:  Blood       Date:  1990-02-15       Impact factor: 22.113

Review 9.  A central role for free heme in the pathogenesis of severe malaria: the missing link?

Authors:  Ana Ferreira; József Balla; Viktória Jeney; György Balla; Miguel P Soares
Journal:  J Mol Med (Berl)       Date:  2008-07-19       Impact factor: 4.599

Review 10.  Advances in graft-versus-host disease biology and therapy.

Authors:  Bruce R Blazar; William J Murphy; Mehrdad Abedi
Journal:  Nat Rev Immunol       Date:  2012-05-11       Impact factor: 53.106

View more
  20 in total

Review 1.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 2.  GVHD: biology matters.

Authors:  James L M Ferrara; Mohammed S Chaudhry
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

3.  A thermogenic fat-epithelium cell axis regulates intestinal disease tolerance.

Authors:  Kevin Man; Christopher Bowman; Kristina N Braverman; Veronica Escalante; Yuan Tian; Jordan E Bisanz; Kirthana Ganeshan; Biao Wang; Andrew Patterson; James R Bayrer; Peter J Turnbaugh; Ajay Chawla
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-30       Impact factor: 11.205

4.  Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.

Authors:  Asim Saha; Patricia A Taylor; Christopher J Lees; Angela Panoskaltsis-Mortari; Mark J Osborn; Colby J Feser; Govindarajan Thangavelu; Wolfgang Melchinger; Yosef Refaeli; Geoffrey R Hill; David H Munn; William J Murphy; Jonathan S Serody; Ivan Maillard; Katharina Kreymborg; Marcel van den Brink; Chen Dong; Shuyu Huang; Xingxing Zang; James P Allison; Robert Zeiser; Bruce R Blazar
Journal:  JCI Insight       Date:  2019-10-03

Review 5.  Disease tolerance: concept and mechanisms.

Authors:  J L McCarville; J S Ayres
Journal:  Curr Opin Immunol       Date:  2017-12-15       Impact factor: 7.486

Review 6.  Mesenchymal stromal cells in hematopoietic cell transplantation.

Authors:  Andre J Burnham; Lisa P Daley-Bauer; Edwin M Horwitz
Journal:  Blood Adv       Date:  2020-11-24

Review 7.  Accommodation and related conditions in vascularized composite allografts.

Authors:  Jeffrey L Platt; Christina L Kaufman; Mayara Garcia de Mattos Barbosa; Marilia Cascalho
Journal:  Curr Opin Organ Transplant       Date:  2017-10       Impact factor: 2.640

8.  IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease.

Authors:  Andrea S Henden; Motoko Koyama; Renee J Robb; Adriana Forero; Rachel D Kuns; Karshing Chang; Kathleen S Ensbey; Antiopi Varelias; Stephen H Kazakoff; Nicole Waddell; Andrew D Clouston; Rabina Giri; Jakob Begun; Bruce R Blazar; Mariapia A Degli-Esposti; Sergei V Kotenko; Steven W Lane; Kate L Bowerman; Ram Savan; Philip Hugenholtz; Kate H Gartlan; Geoffrey R Hill
Journal:  Blood       Date:  2021-08-26       Impact factor: 25.476

Review 9.  GVHD: biology matters.

Authors:  James L M Ferrara; Mohammed S Chaudhry
Journal:  Blood Adv       Date:  2018-11-27

Review 10.  Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease.

Authors:  Gérard Socié; Leslie S Kean; Robert Zeiser; Bruce R Blazar
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.